Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature.

Cristina López-Sánchez, Vicenç Falcó, Joaquin Burgos, Jordi Navarro, María Teresa Martín, Adrià Curran, Lucía Miguel, Inma Ocaña, Esteve Ribera, Manel Crespo, Benito Almirante

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Abstract

© 2015 Wolters Kluwer Health, Inc. As highly active antiretroviral treatment (HAART) is widely available, the incidence of Pneumocystis jirovecii pneumonia (PJP) has decreased significantly but still represents a significant cause of morbidity and mortality in developed countries. We analyzed all the cases with PJP in human immunodeficiency virus (HIV)-infected patients from 2000 to 2013 in a university hospital in Barcelona, Spain, and conducted a systematic literature review to evaluate data regarding incidence, mortality, and long-term survival after PJP in developed settings. One hundred thirty-six episodes of PJP were analyzed. During the study period, the incidence decreased significantly (from 13.4 cases/1000 patients-year to 3.3 cases/1000 patients-year, P<0.001). Oppositely, median age of the patients increased from 34 years in 2000 to 45 in 2013 (P=0.024). PJP preceded HIV diagnosis in nearly 50% of the cases. Fifteen (11%) patients died during the PJP episode. The main risk factor for in-hospital mortality in our cohort was age >50 years (odds ratio 4.96, 95% confidence interval [CI] 1.45-15.14). Patients who survived were followed-up during a mean time of 44 months. Overall 5-year survival of patients after hospital discharge was 73%. Survival likelihood was 54% higher (88% [95% CI 81-96]) among HAART-adherent patients. Mean age and the proportion of patients with unknown HIV infection at the time of PJP diagnosis have increased in developed countries in the HAART era. Although the incidence has decreased, in-hospital mortality remains stable in this setting. Long-term survival is very high among HAART-adherent patients.
Original languageEnglish
Pages (from-to)e681
JournalMedicine (United States)
Volume94
Issue number12
DOIs
Publication statusPublished - 1 Jan 2015

Fingerprint Dive into the research topics of 'Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature.'. Together they form a unique fingerprint.

Cite this